Child pages
  • RIDER Lung CT Segmentation Labels from: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach (RIDER-LungCT-Seg)

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Info
titleData Citation

Description

add abstract

Leonard Wee, Hugo Aerts, Petros Kalendralis and Andre Dekker. (2018) RIDER Lung CT Segmentation Labels from: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. The Cancer Imaging Archive. https://doi.org/

Description

This collection contains images from 32 non-small cell lung cancer (NSCLC) patients based on the public open image collection RIDER Lung CT on TCIA. For these subjects a radiation oncologist was blinded to the all delineations of the 3D volume of the gross tumor volume. They were then asked to manually delineate the gross tumour volume in both the test image and the re-test image. The process was repeated using an in-house autosegmentation method. There is no clinical outcome data associated with this dataset.

This dataset refers to the RIDER dataset of the study published in Nature Communications (http://doi.org/10.1038/ncomms5006). In short, this publication used the dataset to select for repeatable radiomics features in a test-retest context. Radiomics refers to the comprehensive quantification of tumour phenotypes by applying a large number of quantitative image features. In the published analysis, 440 features quantifying tumour image intensity, shape and texture, were extracted. We found that a large number of radiomic features have prognostic power in independent data sets, many of which were not identified as significant before. Radiogenomics analysis revealed that a prognostic radiomic signature, capturing intra-tumour heterogeneity, was associated with underlying gene-expression patterns. These data suggest that radiomics identifies a general prognostic phenotype existing in both lung and head-and-neck cancer. This may have a clinical impact as imaging is routinely used in clinical practice, providing an unprecedented opportunity to improve decision-support in cancer treatment at low cost. 

Info
titlePublication Citation

Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Cavalho, S., … Lambin, P. (2014, June 3). Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nature Communications. Nature Publishing Group. http://doi.org/10.1038/ncomms5006 

Download

  • Original DICOM Image Data - 108 32 subjects (8.5 GB)XX Gbytes)
  • Segmentations (RTSTRUCT / SEG??)Processed NIFTI images with segmentations and radiomic features